FdaApplication
ANDA 206691
Identifiers
- fda_app_no: ANDA206691
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2017-04-14 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PERPHENAZINE | PERPHENAZINE | 8MG | TABLET;ORAL |
| PERPHENAZINE | PERPHENAZINE | 16MG | TABLET;ORAL |
| PERPHENAZINE | PERPHENAZINE | 4MG | TABLET;ORAL |
| PERPHENAZINE | PERPHENAZINE | 2MG | TABLET;ORAL |
4 products